Function of the lectin domain of Mac-1/complement receptor type 3 (CD11b/CD18) in regulating neutrophil adhesion
- PMID: 12444150
- DOI: 10.4049/jimmunol.169.11.6417
Function of the lectin domain of Mac-1/complement receptor type 3 (CD11b/CD18) in regulating neutrophil adhesion
Abstract
A lectin function within CD11b mediates both cytotoxic priming of Mac-1/complement receptor type 3 (CR3) by beta-glucan and the formation of transmembrane signaling complexes with GPI-anchored glycoproteins such as CD16b (FcgammaRIIIb). A requirement for GPI-anchored urokinase plasminogen activator receptor (uPAR; CD87) in neutrophil adhesion and diapedesis has been demonstrated with uPAR-knockout mice. In this study, neutrophil activation conditions generating high-affinity (H-AFN) or low-affinity (L-AFN) beta(2) integrin adhesion were explored. A role for the Mac-1/CR3 lectin domain and uPAR in mediating H-AFN or L-AFN adhesion was suggested by the inhibition of Mac-1/CR3-dependent adhesion to ICAM-1 or fibrinogen by beta-glucan or anti-uPAR. The formation of uPAR complexes with Mac-1/CR3 activated for L-AFN adhesion was demonstrated by fluorescence resonance energy transfer. Conversely, Jurkat cell LFA-1 H-AFN-adhesion to ICAM-1 was not associated with uPAR/LFA-1 complexes, any requirement for GPI-anchored glycoproteins, or inhibition by beta-glucan. A single CD11b lectin site for beta-glucan and uPAR was suggested because the binding of either beta-glucan or uPAR to Mac-1/CR3 selectively masked two CD11b epitopes adjacent to the transmembrane domain. Moreover, treatment with phosphatidylinositol-specific phospholipase C that removed GPI-anchored proteins increased CD11b-specific binding of (125)I-labeled beta-glucan by 3-fold and this was reversed with soluble recombinant uPAR. Conversely, neutrophil activation for generation of Mac-1/CR3/uPAR complexes inhibited CD11b-dependent binding of (125)I-labeled beta-glucan by 75%. These data indicate that the same lectin domain within CD11b regulates both the cytotoxic and adhesion functions of Mac-1/CR3.
Similar articles
-
Role of the lectin domain of Mac-1/CR3 (CD11b/CD18) in regulating intercellular adhesion.Immunol Res. 2002;25(3):219-27. doi: 10.1385/IR:25:3:219. Immunol Res. 2002. PMID: 12018461 Review.
-
Generation of recombinant fragments of CD11b expressing the functional beta-glucan-binding lectin site of CR3 (CD11b/CD18).J Immunol. 1999 Jun 15;162(12):7285-93. J Immunol. 1999. PMID: 10358177
-
Analysis of the sugar specificity and molecular location of the beta-glucan-binding lectin site of complement receptor type 3 (CD11b/CD18).J Immunol. 1996 Feb 1;156(3):1235-46. J Immunol. 1996. PMID: 8558003
-
Urokinase-type plasminogen activator receptor reversibly dissociates from complement receptor type 3 (alpha M beta 2' CD11b/CD18) during neutrophil polarization.J Immunol. 1996 Jan 1;156(1):297-309. J Immunol. 1996. PMID: 8598477
-
Regulation of the adhesion versus cytotoxic functions of the Mac-1/CR3/alphaMbeta2-integrin glycoprotein.Crit Rev Immunol. 2000;20(3):197-222. Crit Rev Immunol. 2000. PMID: 10968371 Review.
Cited by
-
Molecular Interactions of β-(1→3)-Glucans with Their Receptors.Molecules. 2015 May 27;20(6):9745-66. doi: 10.3390/molecules20069745. Molecules. 2015. PMID: 26023937 Free PMC article. Review.
-
Human polymorphonuclear neutrophils specifically recognize and kill cancerous cells.Oncoimmunology. 2014 Jul 3;3(7):e950163. doi: 10.4161/15384101.2014.950163. eCollection 2014. Oncoimmunology. 2014. PMID: 25610737 Free PMC article.
-
The role of lectins and glycans in platelet clearance.J Thromb Haemost. 2011 Jul;9 Suppl 1(0 1):35-43. doi: 10.1111/j.1538-7836.2011.04276.x. J Thromb Haemost. 2011. PMID: 21781240 Free PMC article. Review.
-
Inflammatory response to the ischaemia-reperfusion insult in the liver after major tissue trauma.Eur J Trauma Emerg Surg. 2022 Dec;48(6):4431-4444. doi: 10.1007/s00068-022-02026-6. Epub 2022 Jul 14. Eur J Trauma Emerg Surg. 2022. PMID: 35831749 Free PMC article. Review.
-
A phase I/II trial of beta-(1,3)/(1,6) D-glucan in the treatment of patients with advanced malignancies receiving chemotherapy.J Exp Clin Cancer Res. 2008 Sep 19;27(1):40. doi: 10.1186/1756-9966-27-40. J Exp Clin Cancer Res. 2008. PMID: 18803849 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Research Materials
Miscellaneous